Kersti Oselin
Overview
Explore the profile of Kersti Oselin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laisaar T, Innos K, Jaal J, Oselin K, Sarana B, Vanakesa T, et al.
J Thorac Oncol
. 2024 Aug;
19(8):1138-1145.
PMID: 39112000
No abstract available.
2.
Baum P, Cardoso R, Lenzi J, Damhuis R, Verhagen A, De Gendt C, et al.
Eur J Cancer
. 2024 Jul;
209:114233.
PMID: 39053290
Objective: Harmonized European NSCLC incidence, treatment approach, and survival based on national tumor registries are unclear. Summary Background Data: Surgery has the potential to cure NSCLC and significantly prolong survival....
3.
Tagliamento M, Morfouace M, Loizides C, Oliveira J, Greillier L, Raimbourg J, et al.
NPJ Precis Oncol
. 2024 Feb;
8(1):37.
PMID: 38366021
Arcagen (NCT02834884) is a European prospective study aiming at defining the molecular landscape of rare cancers for treatment guidance. We present data from the cohort of rare thoracic tumors. Patients...
4.
Hochmair M, Unk M, Spasic J, Ceric T, Konsoulova A, Dediu M, et al.
BMC Proc
. 2024 Jan;
18(Suppl 3):2.
PMID: 38233854
Lung cancer remains the leading cause of cancer-related deaths in Europe, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of cases. NSCLC is a heterogeneous disease encompassing various...
5.
Lass J, Leroux S, Korgvee L, Varendi H, Kipper K, Takkis K, et al.
Eur J Clin Pharmacol
. 2023 Dec;
80(2):239-248.
PMID: 38041740
Purpose: Spironolactone is a potassium sparing diuretic used for decades. Until now, pharmacokinetic (PK) studies of spironolactone have not been conducted in infants and therefore pediatric dosing is based on...
6.
OBrien M, Paz-Ares L, Marreaud S, Dafni U, Oselin K, Havel L, et al.
Lancet Oncol
. 2022 Sep;
23(10):1274-1286.
PMID: 36108662
Background: Pembrolizumab is a standard-of-care for advanced non-small-cell lung cancer (NSCLC). We assessed pembrolizumab as adjuvant therapy for completely resected stage IB-IIIA NSCLC. Methods: In this randomised, triple-blind, phase 3...
7.
Oselin K, Pisarev H, Ilau K, Kiivet R
BMC Cancer
. 2021 Mar;
21(1):274.
PMID: 33722202
Background: We aimed to study the mortality and intensity of health care in patients with advanced lung cancer who received systemic anti-cancer treatment (SACT) compared with patients who were not...
8.
Padari H, Soeorg H, Tasa T, Metsvaht T, Kipper K, Herodes K, et al.
Pediatr Infect Dis J
. 2021 Feb;
40(5):464-472.
PMID: 33591074
Background And Aims: Ampicillin is 1 of the most commonly used antibiotics for treatment of early onset sepsis, but its pharmacokinetics (PK) is poorly characterized. We aimed to define the...
9.
Uuskula A, Raag M, Kurvits K, Laius O, Uuskula M, Oselin K
Pharmacol Res Perspect
. 2020 Apr;
8(2):e00577.
PMID: 32232953
Our objective was to examine the trends and variation in opioid prescribing in Estonia from 2011 to 2017. This retrospective cross-sectional study is based on a nationwide prescription medicines database....
10.
Innos K, Oselin K, Laisaar T, Aareleid T
Acta Oncol
. 2019 Jul;
58(11):1549-1556.
PMID: 31286812
Lung cancer (LC) remains the most frequent cause of cancer death worldwide. We aimed to examine long-term trends in LC survival in Estonia by age, gender, histologic type and stage,...